Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: Implications for serological typing and vaccine design

Microbiology

Volumn 142, Issue 1, 1996, Pages 63-69

  Suker, Janet ^a   Feavers, Ian M ^a   Maiden, Martin C J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Antigenic variation; Monoclonal antibody; Neisseria meningitidis; PorA; Serosubtyping

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE; MENINGITIS VACCINE; MONOCLONAL ANTIBODY; OCTAPEPTIDE;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPING; STRUCTURE ACTIVITY RELATION;

EID: 0030052909     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-142-1-63     Document Type: Article

References (31)

1. Abdillahi, H. & Poolman, J. T. (1987). Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 48, 367-371.
2. Abdillahi, H. & Poolman, J. T. (1988a). Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies. FEMS Microbiol Immunol 1, 139-144.
3. Abdillahi, H. & Poolman, J. T. (1988b). Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. Microb Pathog 4, 27-32.
4. Bannister, B. (1988). Clinical aspects of meningococcal disease. J Med Microbiol 26, 161-163.
5. Barlow, A. K., Heckels, J. E. & Clarke, I. N. (1989). The class 1 outer membrane protem of Neisseria meningitidis: gene sequence and structural and immunological similarities to gonococcal porins. Mol Microbiol 3, 131-139.
6. Brooks, J. L., Fallon, R. J. & Heckels, J. E. (1995). Sequence variation in class 1 outer membrane protein in Neisseria meningitidis isolated from patients with meningococcal infection and close household contacts. FEMS Microbiol Lett 128, 145-150.
7. Broome, C. V. (1986). The carrier state: Neisseria meningitidis. J Antimicrob Chemother 18, Suppl A, 25-34.
8. Butcher, S. J., Omar, P. J., Sarvas, M. & Runeberg-Nyman, K. (1991). Sequence comparisons of the class 1 genes from Neisseria meningitidis strains and a folding model of the class 1 protein. In Neisseria 1990, pp. 193-198. Edited by M. Achtman, P. Kohl, C. Marchal, G. Morelli, A. Seiler & B. Thiesen, Berlin: Walter de Gruyter.
9. Caugant, D. A., Høiby, E. A., Magnus, P., Scheel, O., Hoel, T., Bjune, G., Wedege, E., Eng, J. & Frønolm, L. O. (1994). Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 32, 323-330.
10. Delvig, A., Jahn, S., Kusecek, B., Heckels, J. E., Rosenqvist, E., Høiby, E. A., Michaelsen, T. E. & Achtman, M. (1994). A comparison of human and murine monoclonal IgGs specific for the P1.7 PorA protein of Neisseria meningitidis. Mol Immunol 31, 1257-1267.
11. Fine, P. E. (1991). Meningococcal vaccine trial in Norway. Lancet 338, 1456-1457.
12. Frasch, C E. (1985). Status of a group B Neisseria meningitidis vaccine. Eur J Clin Microbiol 4, 533-536.
13. Frasch, C. E. (1989). Vaccines for prevention of meningococcal disease. Clin Microbiol Rev 2, S134-S138.
14. Geysen, H. M., Rodda, S. J., Mason, T. J., Tribbick, G. & Schoofs, P. G. (1987). Strategies for epitope analysis using peptide synthesis. J Immunol Methods 102, 259-274.
15. Hart, C. A. & Rogers, T. R. F. (1993). Meningococcal disease. J Med Microbiol 39, 3-25.
16. van der Ley, P., Heckels, J. E., Virji, M., Hoogerhout, P. & Poolman, J. T. (1991). Topology of outer membrane proteins in pathogenic Neisseria species. Infect Immun 59, 2963-2971.
17. van der Ley, P. & Poolman, J. T. (1991). The class 1 outer membrane protein of Neisseria meningitidis: prediction of topology and construction of a multivalent vaccine strain. In Neisseria 1990, pp. 193-198. Edited by M. Achtman, P. Kohl, C. Marchal, G. Morelli, A. Seiler & B. Thiesen, Berlin: Walter de Gruyter.
18. van der Ley, P., van der Biezen, J. & Poolman, J. T. (1995). Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine 13, 401-407.
19. McGuinness, B. T., Barlow, A. K., Clarke, I. N., Farley, J. E., Anilionis, A., Poolman, J. T. & Heckels, J. E. (1990). Deduced amino acid sequences of class 1 protein PorA from three strains of Neisseria meningitidis. J Exp Med 171, 1871-1882.
20. McGuinness, B. T., Clarke, I. N., Lambden, P. R., Barlow, A. K., Poolman, J. T., Jones, D. & Heckels, J. E. (1991). Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet 337, 514-517.
21. McGuinness, B. T., Lambden, P. R. & Heckels, J. E. (1993). Class 1 outer membrane protein of Nasseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol Microbiol 1, 505-514.
22. Maiden, M. C. J., Suker, J., McKenna, A. J., Bygraves, J. A. & Feavers, I. M. (1991). Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol Microbiol 5, 727-736.
23. Milagres, L G., Ramos, S. R., Sacchi, C T., Melles, C E. A., Vieira, V. S. D., Sato, H., Brito, G. S., Moraes, J. C. & Frasch, C. E. (1994). Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect Immun 62, 4419-4424.
24. Peltola, H. (1983). Meningococcal disease: still with us. Rev Infect Dis 5, 71-91.
25. Poolman, J. T., Kriz Kuzemenska, P., Ashton, F., Bibb, W., Dankert, J., Demina, A., Frøholm, L O., Hassan King, M., Jones, D. M., Lind, P., Prakash, K. & Xujing, H. (1995). Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin Diagn Lab Immunol 2, 69-72.
26. Sanborn, W. R. (1987). Development of meningococcal vaccines. In Evolution of Meningococcal Disease, pp 121-134. Edited by N. A. Vedros. Boca Raton, Florida: CRC Press.
27. Schwartz, B., Moore, P. S. & Broome, C. V. (1989). Global epidemiology of meningococcal disease. Clin Microbiol Rev 2, S118-S124.
28. Sierra, V. G. G., Campa, C. H., Garcia, L I., Sotolongo, F. P., Izquierdo, L. P., Valcarcel, M. N., Casanueva, V. G., Baro, M. S., Leguen, F. C., Rodriguez, R. C. & Terry, H. M. (1991). Efficacy evaluation of the Cuban vaccine VA-MENGOC-BC against disease caused by serogroup B Neisseria meningitidis. In Neisseria 1990, pp. 193-198. Edited by M. Achtman, P. Kohl, C. Marchal, G. Morelli, A. Seiler & B. Thiesen. Berlin: Walter de Gruyter.
29. Suker, J., Feavers, I. M., Achtman, M., Morelli, G., Wang, J.-F. & Maiden, M. C J. (1994). The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol 12, 253-265.
30. Wedege, E., Dalseg, R., Caugant, D. A., Poolman, J. T. & Frøholm, L. O. (1993). Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins. J Med Microbiol 38, 23-28.
31. Witholt, B., Boekhout, M., Brock, M., Kingma, J., van Heerikhuizen, H. & de Leij, L. (1976). An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli. Anal Biochem 74, 160-170.